I am Professor of Molecular Microbiology and Director of the Krebs Institute. My laboratory has worked on S. aureus for over 20 years from basic studies through to translation, to develop vaccines and novel antimicrobials for the control of antibiotic resistant bacteria. A key interest is in bacterial cell structure and dynamics, associated with which he has been at the forefront of implementation of super-resolution microscopy in bacterial cell biology. Another focus of the laboratory has been on S. aureus, host-pathogen interaction and vaccine/antimicrobial development, taking basic findings and translating these into practical outcomes. This has involved substantial industry funding and has ultimately led to the establishment of Absynth Biologics.